System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Tienush Rassaf is an expert in Cardiology at West German Heart and Vascular Center Essen (Germany). As of October 2026, ScienceLeadR ranks Tienush Rassaf in the top 1% of experts worldwide for Cardiotoxicity, Cardiomyopathies and Heart Failure. Tienush Rassaf has authored 807 publications, the most recent in 2026, and is an investigator in 60 clinical trials, 14 of them ongoing. SLR score: 3,659 (community average: 125). How the SLR is computed.

LeadR Profile

Tienush Rassaf West German Heart and Vascular Center Essen Germany
3 659 ScienceLeadR Reputation 3659

Unlock

Register Login
Network Map

Cardiology

Subspecialties: Public Health - Biostatistics - Pharmacy

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2002 - 2026
Source: PubMed

West German Heart and Vascular Center Essen

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 807

Citations

Citations: 23 432 1st author: 49 Last author: 145 Unique author: 8

Main journals

Eur Heart J 91
Eur J Heart Fail 26
Int J Cardiol Heart Vasc 24
JACC Cardiovasc Interv 24
Clin Res Cardiol 19

Best Journals

Eur Heart J 54
N Engl J Med 10
Circulation 3

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
New insights into takotsubo syndrome: results from a multicenter cohort.
PMID 42895542 — heart diseases, emergencies, stress, physiological, brain, recycling, takotsubo cardiomyopathy		Clin Res Cardiol20260
Gut microbiome and metabolite signatures in critical limb threatening ischemia.
PMID 42870417 — genes, rrna, angiography, peripheral arterial disease, gastrointestinal microbiome, ischemia		Vasa20260
Screening for patients at risk for cardiac amyloidosis via electronic health records: A multicenter machine learning development and validation study.
PMID 42848744 — electronic health records, machine learning, amyloidosis, records, learning, radionuclide imaging		PLOS Digit Health20260
Efficacy and safety of alirocumab once-monthly in patients with atherosclerotic cardiovascular disease and without history of an acute atherothrombotic event.
PMID 42827857 — safety, cardiovascular diseases, history		Am J Prev Cardiol20260
A novel likely pathogenic ACTA1 variant is associated with dilated cardiomyopathy in nemaline myopathy.
PMID 42789765 — muscular diseases, cardiomyopathy, dilated, heart failure, myopathies, nemaline, cardiomyopathies		ESC Heart Fail20260

Clinical Studies 60

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 6 Study Chair: 1 Study Director: 2

By phase:

N/A 38
Phase 3 9
Phase 2 6
Phase 4 3
Phase 2/Phase 3 2
Phase 1 1
Phase 1/Phase 2 1

By status:

Completed 30
Recruiting 14
Unknown 7
Active not recruiting 5
Terminated 2
Enrolling by invitation 1
Not yet recruiting 1

By type:

Interventional 39
Observational 21

By Monocentric/Multicentric:

monocentric 30
multicentric2to4 1
multicentric5to9 2
multicentricup10 27

Main Topics

Ongoing Clinical Trials

14 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
A research study comparing CDR132L with placebo on the structure and function of the heart in people with heart failure with reduced mildly reduced ejection fraction and left ventricular hypertrophy
2024-515797-27-00 — hypertrophy, left ventricular, safety, heart failure, heart, hypertrophy, research		Phase 2Recruiting2025
A research study comparing different doses of CDR132L with placebo on the structure and function of the heart in people with heart failure with preserved ejection fraction and left ventricular hypertrophy
2024-515796-35-00 — hypertrophy, left ventricular, safety, heart failure, heart, heart failure, diastolic, hypertrophy, research		Phase 2Recruiting2025
A study to determine if ALXN2220 is effective safe and tolerable in adults with Transthyretin Amyloid Cardiomyopathy (ATTR CM)
2023-506669-70-00 — safety, prealbumin, amyloid, cardiomyopathies, transthyretin amyloid cardiomyopathy, transthyretin amyloidosis		Phase 3Active not recruiting2024
Quality of Life and the Influence of Stress on the Postoperative Course of Patients After Device Implantation
NCT07343466 — quality of life, blood, physical fitness, stress, physiological, cardiac resynchronization therapy, risk factors, therapeutics		N/ARecruiting2025
European Registry of Transcatheter Repair for Tricuspid Regurgitation
NCT06307262 — registries, heart valve diseases, heart diseases, heart failure, heart, tricuspid valve, tricuspid valve insufficiency, heart valves		N/ARecruiting2023

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS